Cargando…
G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States
Autores principales: | Roy, Sunando, Rungsrisuriyachai, Kunchala, Esona, Mathew D., Boom, Julie A., Sahni, Leila C., Rench, Marcia A., Baker, Carol J., Wikswo, Mary E., Payne, Daniel C., Parashar, Umesh D., Bowen, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622260/ https://www.ncbi.nlm.nih.gov/pubmed/26488454 http://dx.doi.org/10.3201/eid2111.150850 |
Ejemplares similares
-
Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(®) and RotaTeq(®) vaccine strains in stool samples
por: Gautam, Rashi, et al.
Publicado: (2014) -
One-step multiplex real-time RT-PCR assay for detecting and genotyping wild-type group A rotavirus strains and vaccine strains (Rotarix® and RotaTeq®) in stool samples
por: Gautam, Rashi, et al.
Publicado: (2016) -
Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study
por: Vesikari, Timo, et al.
Publicado: (2010) -
A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012) -
Characterisation of a rare, reassortant human G10P[14] rotavirus
strain detected in Honduras
por: Quaye, Osbourne, et al.
Publicado: (2018)